<DOC>
	<DOCNO>NCT02841124</DOCNO>
	<brief_summary>The decision limit withdraw specific therapy ( DLWT ) patient advanced cancer complex process always painful patient , relatives professional . For 10 year , share decision make emphasize . However , data literature rely clinical research . In order understand difficulty issue , study explores determinant modality DLWT analyse feasibility different method investigate decision making process .</brief_summary>
	<brief_title>Decision Limit Withdraw Specific Therapies Advanced Cancer Hematological Malignancies .</brief_title>
	<detailed_description>This study explore decision-making process patient advance cancer question imit withdraw specific therapy ( DLWT ) raise , cross-analysis physician pts point view . This study take place 5 oncology hematology unit : 2 university hospital , 1 general hospital , 1 cancer center 1 private hospital . The study include two different approach : epidemiological section identify prevalence situation different institution qualitative study section explore factor influence decision process . The epidemiological analysis include hospitalized patient identify advanced cancer question DLWT raise give week two week precede investigation . The qualitative analysis base interview referent oncologist ( hematologist ) patient ( conducted physician psychologist respectively ) well interviews partner involve situation ( care staff relative ) depend center . Researchers also participate multidisciplinary meeting monitor change decision three month period .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Patients advance cancer Existence question DLWT Absence guide line Incapacity patient participate interview Absence inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Decision making</keyword>
</DOC>